Funding | Requests for Proposals: Hep B Birth Dose Advocacy in Africa (Deadline November 2, 2023)

Request for Proposals: Civil Society Organizations (CSOs) Developing Campaigns for Hep B Birth Dose (HepB-BD) Advocacy in Africa

Application Deadline: November 2, 2023 @ 11:59 PM EST
Expected number of awards: up to 6
Estimated Total Program Funding: up to $20,000

The Coalition for Global Hepatitis Elimination (CGHE) is seeking requests for funding proposals (RFP) from national and regional Civil Society Organizations (CSOs) in Africa to improve awareness of the importance of HepB-BD vaccination among pregnant persons, their families, health care workers (HCWs) and public and policy makers.

In collaboration with the Global Immunization Division/US CDC (GID) and the World Health Organization (WHO), CGHE began convening stakeholders in a community of practice toward the successful introduction and scale-up of HepB-BD vaccine for member states of the WHO African region (AFRO). In partnership with the US CDC and the WHO’s Headquarters and Regional Office for Africa, CGHE also developed a HepB-BD toolkit for national immunization technical advisory groups (NITAGs) to provide background, data, and best practices for introducing a HepB-BD program in African countries. In 2022, CGHE supported CSOs in African countries to promote timely HepB-BD vaccination through community sensitization and advocacy for HepB-BD policy change. A compilation of activities and materials from previously funded CSOs can be found here

Proposal Categories:

• Proposals will be accepted in two categories, A and B:
  • Category A. CSOs in African countries that have adopted HepB-BD policy (with coverage less than 75%): Category A applicants will focus on advocacy activities that promote implementation of HepB-BD vaccination by improving awareness and understanding among pregnant persons, their families, birth attendants, other clinicians and public health officials of the health benefits of HepB-BD vaccination and the strategies to deliver hepatitis B vaccinations to newborns in the country.
  • Category B. CSOs in African countries that have yet to adopt HepB-BD policy: Category B applicants will focus on activities to advocate for HepB-BD policy development through increasing awareness and understanding of the health benefits of HepB-BD vaccination among policy-makers, healthcare workers, and the community, by building political will, and creating demand among pregnant persons, their families and healthcare workers.

Funding Information:

• Proposals can be submitted to one of three available funding categories:
  • Up to $20,000
  • Up to $13,000
  • Up to $7,500
• Up to 6 CSOs will be selected as part of this initiative. Depending upon the quality of applications, CGHE intends to fund 2 applicants in each funding category. CGHE may request a revised scope of work and budget from applicants. CGHE reserves the right to release funds throughout the project implementation period based on evidence of satisfactory performance and progress by each CSO.

Required Activities:

• Category A:
  • Develop infographics, audio/visual recordings, posters, and other communications materials with key messages (using local language(s) as appropriate) to increase HepB-BD vaccine implementation.
  • Design a coordinated campaign to reach target populations using platforms such as mass media, radio, TV, public events, and/or trainings.
  • Engage key stakeholders in providing feedback on communications materials and campaign design.
  • Execute the communications campaign
  • Evaluate impact of activities
• Category B:
  • Hold at least 1 high-level meeting with Ministry of Health officials and other policy makers to secure support for HepB-BD policy development
  • Develop infographics, audio/visual recordings, posters, and other communications materials with key messages (using local language(s) as appropriate) to increase political will for adopting HepB-BD policy
  • Design a coordinated campaign to reach target populations using platforms such as mass media, radio, TV, public events, and/or trainings
  • Engage key stakeholders in providing feedback on communications materials and campaign design
  • Execute the communications campaign
  • Evaluate impact of activities

Eligible Countries:

• Countries with established policy or NITAG decisions to adopt HepB-BD with coverage <75%
  • Angola
  • Benin
  • Botswana
  • Côte d’Ivoire
  • Equatorial Guinea
  • Gambia
  • Nigeria
  • Mauritania
  • Mauritius
  • Sao Tome and Principe
  • Senegal**
• Countries with recent policy or NITAG decisions to adopt HepB-BD (with coverage <75%) or that have not implemented yet
  • Burkina Faso
  • Ghana
  • Malawi
  • South Africa
  • Uganda
• If your country is not listed but has adopted HepB-BD policy, in your application, please provide documentation of government adoption of a HepB-BD policy.
• Senegal** applications will be considered since coverage has varied over recent years and has declined for consecutive years.
• Note: Algeria, Cabo Verde, and Namibia have adopted HepB-BD policy, however, HepBBD coverage is greater than 75%. Therefore, these three countries are not included on this list.

Target populations:

• Category A:
  • Health officials
  • Healthcare providers, particularly birth attendants
  • Community health workers
  • Community leaders
  • General public, particularly, pregnant persons, women of child bearing age and their families
• Category B:
  • Political leaders and policymakers
  • Senior health officials
  • Maternal and child healthcare providers
  • Community leaders
  • General public, particularly, pregnant persons, women of child bearing age and their families

View and Download the Complete RFP Requirements here

View and Download Optional Proposal Template here

For questions or assistance, email globalhep@taskforce.org

Last Updated on October 7, 2024 by HepFree NYC